February 14, 2018
Wilson Therapeutics to host conference call to provide fourth quarter 2017 business update
Media
February 07, 2018
Targovax announces completion of safety lead-in and preliminary immune activation data in ONCOS-102 trial in mesothelioma
February 07, 2018
Q4 2017 General Market Overview
February 06, 2018
Targovax ASA: Invitation to fourth quarter and full year 2017 results presentation Thursday 15 February
February 01, 2018
BONESUPPORTTM repays outstanding loan from Kreos
February 01, 2018
2017 ANNUAL RESULTS AND UPDATE ON TANGO
February 01, 2018
Nordic Nanovector Appoints Malene Brondberg as Vice President, Investor Relations and Corporate Communications
January 25, 2018
GenSight Biologics reports €55 million 2017 year-end cash position and provides corporate update
January 25, 2018
Cash position and activity update for Q4 2017
January 25, 2018
Onxeo receives EPO Intent-to-Grant Notice for key AsiDNA™ patent, extending IP protection in Europe until 2031